Disease spotlight: LHON

Newsletters and Deep Dive digital magazine
As Economist Impact’s World Cancer Series continues, Day Two firmly takes up focus on the patient voice, with a presentation by Eileen Page, chief executive of Innovation Advantage 2020 to
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho
To continue delivering high-quality and patient-centred care, the future oncology workforce of the NHS needs to be agile, expansive, and diverse.
It’s about that time of year when many global teams turn their attention towards annual strategic planning.
Coaching has developed into one of the most powerful tools in a fast-changing pharmaceutical sector.
WASHINGTON, D.C., Sept.
The 2nd Innate Killer Europe Summit will gather 80+ key European Gamma Delta T, NK, iNKT, neutrophil, and macrophage developers in October to chase the holy grail of efficacious, off-the-sh
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox
Editor's Picks